| |
Here we summarise the data generated by our last EQAPs between 1999 and 2007:
| Time |
Virus |
Methods |
Participants |
Countries |
N° of samples
pos/neg |
good results |
Ref. |
| 1999/2000* |
Hanta |
Serology |
13 (13)† |
10 |
3/1 |
11 (85%) |
1 |
| 2001/2002 |
Hanta |
Serology |
18 (16) |
14 |
14/6 |
13 (72%) |
1 |
| 1999* |
Dengue |
Serology |
13 (13) |
10 |
2/2 |
11 (85%) |
2 |
| 2002 |
Dengue |
Serology |
18 (16) |
16 |
18/2 |
15 (83%) |
2 |
| 2002/2003 |
Dengue |
PCR |
13 (11) |
12 |
7/3 |
5 (38%) |
3 |
| 2002/2003 |
Filo |
PCR |
14 (12) |
13 |
7/5‡ |
7 (50%) |
4 |
| 2002/2003 |
Lassa |
PCR |
14 (12) |
13 |
8/5‡ |
8 (57%) |
4 |
| 2002/2003 |
Orthopox |
PCR |
23 (21) |
15 |
13/5‡ |
18 (78%) |
4 |
| 2004 |
SARS |
PCR |
62 (34) |
37 |
7/3 |
54 (87%) |
5 |
| 2004 |
SARS |
Serology |
30 (14) |
19 |
5/6 |
13 (43%) |
6 |
| 2004/2005 |
Orthopox |
PCR |
33 (27) |
18 |
9/6 |
28 (85%) |
7 |
| 2005 |
WNV |
PCR |
30 (23) |
18 |
7/5 |
8 (27%)⊗ |
8 |
| 2005 |
WNV |
Serology |
27 (20) |
21 |
4/6 |
8 (30%) |
9
|
| 2005/2006 |
TBE |
PCR |
21 (19) |
17 |
9/3 |
11 (48%) |
10 |
| 2005/2006 |
TBE |
Serology |
37 (35) |
27 |
7/5 |
25 (60%) |
11 |
| 2007 |
Chikungunya |
PCR |
31 (22) |
23 |
9/3 |
14 (45%) |
12 |
| 2007 |
Chikungunya |
Serology |
30 (20) |
23 |
6/4 |
9 (30%) |
13 |
* Pre-evaluation panel tested before running the respective EQA to optimise sample preparation
and shipping procedures
† in brackets n° of European laboratories
‡ The same negative samples were included in the test panels for Filo, Lassa, orthopox
⊗ Results for both WNV lineages 1 & 2
p.i.p. = publication in preparation
For more details on our references please click here
|